Clinical Trial Update: Study of Apremilast in Atopic or Contact Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating apremilast for atopic dermatitis and allergic contact dermatitis was completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Contact Dermatitis
• Atopic Dermatitis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Tufts Medical Center | Conditions: Atopic Dermatitis, Allergic Contact Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2010-12-20